American International Group, Inc. (NYSE: AIG) — A Repaired Franchise at One Times Book, Priced for the Cost of Capital
Independent equity research note Report date: June 21, 2026 · Sector: Financials · Property & Casualty Insurance · CIK 0000005272 Price reference: ~$74.02 (NYSE close, June 18, 2026) · Market cap ~$39.2B · ~538M shares · Book value/share $74.24 (tangible $66.76)
⚡ Claude’s Take
This block is the author’s own subjective opinion. It is general information and not investment advice. The analysis that follows it is written position-free; this opening block is the single place a directional view is expressed.
Verdict: HOLD / accumulate-on-weakness. Not a short. AIG is a genuinely repaired franchise — but the repair, and the easy re-rating that came with it, are largely behind the stock. At ~$74 it trades at ~1.0x book / ~1.11x tangible book / ~10.4x clean operating earnings (AATI), which is the cheapest price-to-book in the quality commercial-P&C set (Chubb ~1.7x, Travelers ~2.0x) — but also near the rich end of AIG’s own decade (AZI composite valuation percentile ~71st; AIG spent its entire post-GFC life at 0.5–0.7x book). Both facts are true at once, and the whole debate is which reference frame governs. My read: a P&C insurer at 1.0x book is the market underwriting a sustainable ROE of roughly its cost of equity (~9.5–10%) and no more — which is almost exactly AIG’s realized 9.4% adjusted / 11.1% core-operating ROE. There is essentially no re-rating optionality priced in, which cuts both ways: limited downside to a fixed, AA‑rated, capital‑returning insurer, but limited free upside unless core operating ROE durably pushes through ~12% while the property cycle softens — a real “show-me.” I’d accumulate toward ~$66–68 (≈0.9x book) where the margin of safety is clearer, see fair value at ~$78–92 (1.05–1.25x book if ROE holds 11–12%), and reserve genuine enthusiasm for a washout into the low-$60s or hard evidence the turnaround margins survive a normal cat year and a seasoned casualty book.
Framing: this is an out-of-favor, low-beta (0.55) value/mean-reversion insurer, not a momentum name and not a violent falling knife — it has bled ~14% off its December‑2025 high on soft-market worry, NII plateau, and a CEO handoff, with a 12‑month max drawdown of only ~17%. The market is correctly pricing the low ROE; it is debating, not yet rewarding, the durability of the fix. Conviction: medium. Single fact that flips me bullish: core operating ROE sustained ≥12% for 3–4 quarters with property rates falling and the underlying accident-year combined ratio holding ~88–90. Single fact that flips me bearish: a casualty/social-inflation reserve charge worth >1–2 points of ROE, or the underlying combined ratio drifting above ~92 as the cycle turns. Tag: “Fixed, financed, and fully valued for what it currently earns — the re-rate is now an ROE bet, not a balance-sheet bet.”
📈 Stock Price Action — Five-Year Event Map
AIG round-tripped a long, grinding turnaround: from a ~$40 post-COVID low (mid-2021), up a multi-year recovery climb to a modern post-split high of ~$86 (December 23, 2025), then a ~14% give-back to $74.02 (June 18, 2026). The 52-week range is roughly $71–$86; the stock now sits just below its falling 200-day EMA (~$76.4) — the tape of a low-volatility value name mean-reverting off a peak, not a crash. (Source: AZI 5-year price CSV, accessed 2026-06-21.)
| # | Period | Approx. move | Price (~from → to) | Primary driver(s) | Fact / Interp |
|---|---|---|---|---|---|
| 1 | Jul–Dec 2021 | +28% | ~$40 → $51 | Reflation rally + “AIG 200” cost program + announced plan to separate Life & Retirement (Corebridge) | F / Interp |
| 2 | Q1–Sep 2022 | −23% | ~$57 → $44 | 2022 rate-shock bear market; soft Corebridge IPO (priced $21, Sep-15-2022, the largest US IPO of the year) | F / Interp |
| 3 | Oct 2022–Jan 2023 | +34% | ~$44 → $58 | General Insurance combined-ratio improvement + buyback ramp + rising net investment income | F / Interp |
| 4 | 2023 | net ~+10% | ~$58 → $64 | Corebridge sell-downs; Validus Re sale to RenaissanceRe announced; continued buyback | F / Interp |
| 5 | 2024 | ~+10% choppy | ~$64 → $70 | Share count −37% since 2020; margin discipline; capped by NII plateau and softening property rates | F / Interp |
| 6 | 2025 | ~+22% to peak | ~$70 → $86 | Ratings inflection (S&P AA-, first since 2013; Moody’s A1, first since 1990; AM Best positive); core ROE 11.1% | F / Interp |
| 7 | Jan–Jun 2026 | −14% | ~$86 → $74 | Soft-market worry (property −10/−13%); NII tailwind spent; CEO handoff (Zaffino→Andersen); houses Equal-Weight | F / Interp |
- 2021 reflation + separation plan: the stock re-rated off its lows as the “new AIG” thesis — simplify, cut costs, separate Life — took hold. (Price = FACT; attribution = INTERPRETATION.)
- 2022 bear + Corebridge IPO: the macro rate shock dominated; the Corebridge IPO priced soft at $21, monetizing the life unit but at a discount.
- 2022–23 underwriting turn: AIG’s commercial combined ratio fell decisively into the high-80s and net investment income rose with rates, driving a sharp recovery.
- 2023 de-risking: Validus Re (the most catastrophe-volatile book) was sold to RenaissanceRe (~$3.3B, closed Nov 1, 2023); Corebridge sell-downs continued; the balance sheet simplified.
- 2024 buyback grind: earnings-per-share growth was carried heavily by a shrinking share count even as net investment income plateaued and property rates began to soften.
- 2025 ratings vindication: two-notch ratings upgrades independently confirmed the balance-sheet repair; core operating ROE crossed 11% — the first sustained double-digit print in a decade — and the stock made new highs.
- 2026 give-back: with the turnaround “done,” the market shifted to the harder question — can a now-good franchise sustain double-digit ROE through a softening property cycle under a brand-new CEO? The stock drifted lower on those doubts, not on any operating miss.
1. Executive Summary
American International Group is no longer the sprawling, twice-bailed-out financial conglomerate of the last cycle. Under Peter Zaffino (CEO 2021–May 2026; now Executive Chair), AIG executed one of the more complete corporate transformations in large-cap financials: it separated and fully exited its Life & Retirement business (Corebridge Financial), sold its most volatile reinsurance book (Validus Re), cut its debt by roughly two-thirds, retired ~37% of its shares, and drove its remaining commercial P&C operation to combined ratios that now sit within striking distance of Chubb’s. The market has acknowledged this: the stock re-rated from a chronic ~0.6x book to ~1.0x book, and in 2025 the rating agencies handed down their first upgrades in 12–35 years (S&P to AA-, Moody’s to A1, AM Best to a positive a+).
The investable question is therefore no longer “can it be fixed?” but “what is a fixed-but-still-follower commercial P&C insurer worth, and how much of the re-rate is left?” Our answer is nuanced. On clean operating metrics — adjusted after-tax income (AATI) of $4,044M (diluted $7.09/sh, +43% YoY), adjusted ROE 9.4%, core operating ROE 11.1% (FY25) rising to 12.2% in Q1 2026 — AIG earns meaningfully more than its 7.6% GAAP ROE implies (the GAAP figure is distorted by Corebridge deconsolidation and AOCI). That clean ROE supports the move to ~1.0x book. But it also caps the bull case: ~11–12% is good, not elite. Chubb earns ~14–15% and is awarded 1.7x book; Travelers ~18–20% at 2.0x. AIG is structurally the #3–#4 commercial P&C franchise — competitive in global specialty, multinational, and E&S niches, but a follower without Chubb’s wide cost-and-underwriting moat, dragged by a sub-scale, near-breakeven personal-lines book (Global Personal combined ratio 99.0).
The numbers behind the moat verdict are telling: AIG’s segment-level commercial combined ratios (NA Commercial 86.8, International Commercial 86.9) are nearly Chubb-class, yet its consolidated returns are not — the gap is the personal book, a higher expense ratio (31.1% vs Chubb’s high-20s), and the fact that the calendar-year combined ratio has been flattered by a light 2025 catastrophe year ($258M) and favorable prior-year development concentrated in property and financial lines, not casualty. The underlying accident-year ex-cat combined ratio has been roughly flat at ~88 for three years. Meanwhile the two macro tailwinds that lifted every P&C insurer — the post-2021 hard market and the surge in net investment income — are maturing: property rates are now falling 10–13%, and NII has plateaued at ~$4.07B.
Capital allocation has been the standout. ~$19–20B returned to shareholders over three years, funded by ~$20B of Corebridge monetization, much of it repurchased at or below book (genuinely accretive); a fourth consecutive double-digit dividend raise (to $0.50/quarter); and a compensation scheme with a real combined-ratio-and-ROE governor. This is the strongest capital-allocation record among its commercial-P&C peers. Insiders, however, have not bought a single share on the open market through the turnaround — a neutral tell, not a conviction signal.
Valuation embeds almost no re-rating optionality: at 1.0x book the market is underwriting a sustainable ROE of ~9.5–10% — its cost of equity. The setup is a classic out-of-favor, low-beta value insurer (beta 0.55, down ~14% off its high, lagging the tape) where consensus is offsides on durability if the ROE proves out, and correctly cautious if it does not. The body that follows takes no position; the author’s opinion is fenced in Claude’s Take above.
2. Business Overview
What AIG is today (FACT). American International Group is a global, commercial-led property-casualty insurer. After a four-year reshaping, essentially all of its earnings now come from one reporting franchise — General Insurance (GI) — supplemented by corporate/“Other Operations” and the now-fully-exited equity stake in Corebridge Financial. The company underwrites for commercial, institutional, and high-net-worth individual clients across North America and ~190 countries/jurisdictions, distributing through brokers, agents, and wholesale channels. It employs ~22,200 people and is headquartered in New York. (Source: AIG FY2025 Form 10-K, filed 2026-02-12; company profile.)
Segment structure and FY2025 results (FACT). General Insurance reports in three pieces:
| Segment | FY2025 NPW | Combined ratio | Character |
|---|---|---|---|
| North America Commercial | $8,759M | 86.8 | Casualty, financial lines, specialty, retail/E&S (Lexington) |
| International Commercial | $8,663M | 86.9 | Global specialty, multinational, energy/marine/aviation, Talbot/Lloyd’s |
| Global Personal | $6,253M | 99.0 | High-net-worth (Private Client), travel, personal accident & health |
| GI total | $23,675M | 90.1 | (~88.3 accident-year-adjusted) |
(Source: AIG FY2025 10-K; segment disclosures.) Commercial lines are ~73% of net premiums written — AIG is fundamentally a commercial/specialty underwriter with a smaller personal franchise attached. GI adjusted pre-tax income was $5,765M (+16% YoY), of which net investment income contributed $3,433M (+12%).
How it makes money (FACT/INTERPRETATION). Like any P&C insurer, AIG earns from two engines: (1) underwriting margin — premiums earned less losses and expenses, summarized by the combined ratio (below 100 = an underwriting profit); and (2) net investment income on the “float” — premiums held between collection and claim payment, invested largely in high-grade fixed income. At a ~90 combined ratio AIG now makes money on both engines, a meaningful change from its troubled decade when underwriting losses were chronic. The recurring nature is high: commercial insurance renews annually with sticky broker relationships, and float compounds as long as the book is reserved adequately.
The transformation context (FACT). The headline revenue collapse from $52.0B (2021) to $26.8B (2025) is almost entirely the deconsolidation of Life & Retirement (Corebridge), not a shrinking insurance operation. AIG IPO’d Corebridge in September 2022 (CRBG) and sold down its stake over 2023–2025; in February 2026 Nippon Life (a strategic buyer) waived AIG’s retention requirement, and AIG sold its final shares by ~May 2026, fully exiting. Management states it realized ~$20B cumulatively from Corebridge and replaced 100% of the lost Corebridge + Validus Re earnings within roughly two years via underwriting growth, NII, and buyback accretion. (Source: AIG investor materials; BusinessWire 2026-05-05; Q1-26 transcript.)
Verdict. AIG is now a clean, focused, commercial-led global P&C insurer with genuine recurring economics on both underwriting and investment income — a structurally simpler and higher-quality business than the conglomerate it was. The quality gap to best-in-class peers lives in the personal-lines drag and a higher cost base, addressed in.
3. Industry Dynamics
Structure (FACT/INTERPRETATION). Commercial P&C insurance is a large, fragmented, cyclical industry organized around an underwriting “soft/hard” cycle: when capital is plentiful and losses benign, competition drives rates down (soft market); when capital is impaired by catastrophes or reserve shocks, rates harden. Profit pools concentrate in specialty and excess & surplus (E&S) lines — aviation, marine, energy, political risk, trade credit, professional/financial lines, large-account casualty — where underwriting expertise, global licensing, and balance-sheet size create real (if shared) barriers. Commodity lines (workers’ comp, small commercial, much of personal) are more price-competitive.
Where we are in the cycle (FACT). The 2019–2023 hard market — driven by social inflation, COVID-era loss uncertainty, and 2017–2022 catastrophe activity — has matured and is now bifurcating:
- Property rates are falling. With record reinsurance capacity and a benign 2024–2025 catastrophe experience, property pricing has turned negative: AIG cites North America property rate change of roughly −10% to −13%, with large-account E&S property down more (down ~30% at the worst). (Source: AIG Q4-25 / Q1-26 transcripts.)
- Casualty is still firming. Long-tail casualty rates remain positive (roughly +8% to +15%, above loss-cost trend) as carriers respond to social inflation — rising jury verdicts, litigation funding, and adverse legal trends. This is simultaneously a pricing tailwind and a reserve risk.
Marathon capital-cycle lens (INTERPRETATION). Applying the Marathon (Capital Returns) supply-side framework: the property segment displays late-cycle characteristics — high industry returns over 2021–2024 have attracted capital (new reinsurance vehicles, ILS, abundant retro), which is now compressing prices. That is the classic signal that property underwriting margins are at or near a cyclical peak and will mean-revert. Casualty is earlier in its repricing but carries the offsetting danger that today’s “adequate” rates may prove inadequate if social inflation accelerates — i.e., the reserve cycle, not just the price cycle, matters. AIG’s heavier casualty/specialty weighting and deliberate property shrinkage modestly insulate it from the property softening, but do not exempt it.
Regulation and reinsurance (FACT). P&C insurers are state-regulated (solvency, rate filings) but far less rate-constrained than personal auto/health; commercial and specialty pricing is largely market-set. Reinsurance is a critical input — cheap, abundant reinsurance currently helps cede catastrophe volatility at attractive terms (a tailwind to net combined ratios), but that same abundance is what is softening primary property rates.
Verdict: structurally mediocre, mid-cycle, and softening. Commercial P&C is a decent-not-great industry — better than personal lines, worse than capital-light insurance brokerage. Sector ROEs that touched the mid-teens in the hard market are projected to fade toward ~10–12% as property softens. The cycle is past its peak. This is a headwind that AIG’s casualty/specialty mix only partly offsets — and it is the single most important reason to doubt that AIG’s recent combined-ratio improvement is fully structural.
4. Competitive Position
Does AIG have a moat? (INTERPRETATION — the central question.) Partially, and narrowly. In the Greenwald taxonomy, AIG possesses real but shared scale-and-captivity advantages in a handful of niches: global multinational programs (few carriers can write a coordinated policy across 190 jurisdictions), large-account specialty (aviation, marine, energy, political risk, trade credit), E&S via Lexington, and Lloyd’s via Talbot. These create genuine demand-side captivity — a multinational client cannot easily replicate AIG’s licensing footprint and claims network — but the advantage is shared with roughly four peers (Chubb, AXA XL, Zurich, Allianz/AGCS) and is therefore an oligopoly position, not a monopoly moat.
The clinching evidence the moat is shallow: the ROE gap. The most direct test of competitive advantage is whether it shows up in returns. AIG’s segment commercial combined ratios are now near Chubb-class (NA Commercial 86.8, International 86.9), yet its consolidated return on equity is not:
| Company | Combined ratio | ~ROE | ~P/B | Read |
|---|---|---|---|---|
| AIG | 90.1 (GI) | ~9–11% | ~1.00x | Cheapest book, lowest ROE — the follower |
| Chubb (CB) | low-80s | ~14–15% | ~1.7x | Wide-moat quality benchmark, AA balance sheet |
| Travelers (TRV) | ~90 | ~18–20% | ~2.0x | Highest ROE/book in the large-cap set |
| W.R. Berkley (WRB) | ~90 | ~20%+ | ~2.5x | Specialty compounder |
| Arch Capital (ACGL) | ~80s–low90s | ~15–18% | ~1.6–1.8x | Specialty/reinsurance, cycle-savvy |
(Peer figures from public filings and market data for Chubb (CB) and Travelers (TRV); AIG figures from its FY2025 Form 10-K.)
That AIG can match Chubb on commercial combined ratio but earns ~4–5 points less ROE tells you the advantage is shallow and the drags are structural:
- Personal-lines drag (FACT): Global Personal runs a 99.0 combined ratio — barely profitable — and is being deliberately shrunk to quality (the high-net-worth Private Client book partly moved to a Stone Point-backed MGA, Private Client Select). This is a competitive concession to Chubb, which is expanding HNW. A near-breakeven sixth of the book mathematically caps blended returns.
- Cost disadvantage (FACT): AIG’s GI expense ratio is 31.1%, versus Chubb’s high-20s. The “AIG Next” program (below) targets <30% by 2027, but a structural cost gap to the best operator remains.
- Calendar-vs-underlying flattery (INTERPRETATION): The reported 90.1 (and 84.9 in 2024) combined ratio benefits from a light 2025 cat load and favorable prior-year development (+$472M FY25), which came from property and financial lines, not casualty. The underlying accident-year ex-cat combined ratio has been ~flat at ~88 (88.3 / 88.2 / 87.7 over 2025/24/23). Strip the cycle help and AIG’s underwriting is good but not visibly improving.
Switching costs and brand (INTERPRETATION). Real but modest. Commercial insurance is broker-intermediated; switching is an annual renewal decision driven by price, capacity, and claims reputation. AIG’s brand carries scars from the 2008 era but has been substantially rehabilitated (the ratings upgrades are the external proof). Claims-paying reputation and global servicing create some captivity in complex risks, but little in commoditized lines.
Verdict: a narrow, shared advantage — a strong #3–#4 franchise, not a wide-moat franchise. AIG has rebuilt itself into a credible top-tier commercial specialist with genuine niche captivity and a now-pristine balance sheet, but it lacks Chubb’s durable cost-and-underwriting edge and carries a sub-scale personal book. The competitive position is good and defensible, not dominant — which is precisely why the market pays it the cheapest multiple of the quality set.
5. Growth History and Forward Opportunities
History (FACT). AIG’s premium base has been flat-to-down by design as management pruned underperforming books. Net premiums written in General Insurance have not grown in aggregate — NA Commercial NPW actually fell from ~$11.4B (2023) to $8.76B (2025) as AIG sold Validus Re, exited Crop Risk Services, restructured reinsurance, and shed large-account E&S property. The reported EPS growth (diluted AATI/sh +43% in 2025) was driven overwhelmingly by (a) the NII tailwind, (b) margin/expense improvement, and © the ~37% reduction in share count — not by volume.
Organic vs. rate vs. exposure (INTERPRETATION). Net of the pruning, AIG’s true organic premium growth is modest — International Commercial grows steadily (~+2–4%), but the consolidated book is roughly flat. “Growth” has been overwhelmingly rate, retention, mix-shift, and capital return, plus the exogenous lift from higher investment yields. This is low-quantity growth.
Forward opportunities (FACT/INTERPRETATION). Management is pivoting from “shrink to quality” toward selective expansion, increasingly via strategic transactions rather than organic underwriting:
- Everest renewal-rights deal (~$1.8B of premium, with ~75% January retention and a claimed ~10-point combined-ratio benefit relative to organic) — a bolt-on book at attractive economics.
- Convex — a ~35% equity stake plus a whole-account quota share, giving AIG capacity and returns in specialty/reinsurance without full balance-sheet commitment.
- Capital-light “fronting”/SPV structures — e.g., Syndicate 2479 with Amwins and Blackstone — that grow fee and ceded-commission income.
- Casualty and specialty redeployment — moving capital from softening property into firming casualty (above loss-cost trend) and high-margin specialty.
- International — the firmer non-US cycle (~40% of Global Property is international) and multinational franchise offer better organic prospects than the soft US market.
Management explicitly stated these deals are “more accretive in 2026–2027 than buybacks” — a notable signal that the buyback-at-book era of value creation is maturing and the next leg must come from underwriting and deployed capital. (Source: Q1-26 transcript.)
Verdict: low-quantity, mixed-quality growth. AIG is not a premium-growth story; it is a margin, capital-return, and (increasingly) bolt-on-deal story. The forward opportunities (Everest, Convex, casualty redeployment) are sensible and capital-efficient, but they are additive, not transformational, and they shift the value-creation burden from the near-finished buyback program onto underwriting execution under a new CEO. The growth is good enough to support double-digit EPS growth if margins hold — but it is not the kind of secular, high-return compounding that earns a premium multiple.
6. Financial Quality
The quality-of-earnings crux (FACT/INTERPRETATION). AIG’s 7.6% GAAP ROE is not the operating reality. GAAP net income and book value have been whipsawed for four years by the Corebridge deconsolidation (large non-operating gains and losses), AOCI swings on the bond portfolio, and realized investment gains/losses. The clean read uses management’s adjusted metrics, which reconcile transparently in the filings:
- Adjusted after-tax income (AATI): $4,044M (FY2025), diluted $7.09/share (+43% YoY).
- Adjusted ROE 9.4%; Core Operating ROE 11.1% (the latter excludes AOCI and certain legacy items) — above management’s stated “10%+” target and the first sustained double-digit operating ROE in a decade.
- Q1 2026: core operating ROE 12.2%; AATI/share $2.11 (+80% YoY); GI underwriting income roughly tripled to $774M; GI combined ratio 87.3.
Use core operating ROE (~11–12%) as the true earning power. It justifies the move to ~1.0x book — but it also caps the bull case below Chubb/Travelers.
Combined ratio trajectory (FACT). GI calendar-year combined ratio: 87.4 (2023) → 84.9 (2024) → 90.1 (2025 reported; segment GI ex-personal materially better). The skeptic’s flag, repeated because it matters: the underlying accident-year ex-cat combined ratio is roughly flat at ~88 across all three years (88.3 / 88.2 / 87.7). The calendar improvement leans on a light 2025 catastrophe year ($258M) and favorable prior-year reserve development (+$472M) sourced from property and financial lines. Q1-26’s ~850bps headline GI combined-ratio improvement was mostly catastrophe normalization (versus Q1-25’s California wildfires); the durable piece was a ~120bps underlying improvement.
Net investment income (FACT). NII has plateaued at ~$4.07B (FY25, roughly flat-to-down 1% YoY). The rate-driven tailwind that powered 2022–2024 earnings is largely spent; incremental NII growth now depends on portfolio reinvestment at the margin and asset growth, not on rising yields.
Reserves and social inflation (FACT/INTERPRETATION — the key risk line). Favorable development is coming from short-tail lines; meanwhile the CFO has disclosed adding margin to long-tail casualty loss picks for social inflation and litigation trends. In plain terms: AIG is taking conservative casualty reserves today while harvesting redundancy elsewhere. This is prudent, but it means (a) the favorable development flattering the calendar ratio is not from the riskiest book, and (b) the adequacy of the casualty reserves is the single most important unverifiable assumption in the whole thesis — AIG’s franchise was nearly destroyed by casualty reserve deficiencies in prior cycles.
Balance sheet and ratings (FACT). The balance sheet is now a genuine strength:
- Debt cut from $30.2B (2020) to $9.19B (2025); interest expense from ~$1.3B to ~$0.4B; debt-to-capital ~18%.
- AOCI swung from roughly −$14.8B (2023) toward −$1.4B (2025) as bonds pull to par — a quiet tailwind to adjusted book value as it reverses.
- Ratings double-upgrade in 2025: S&P to AA- (first upgrade since 2013), Moody’s to A1 (first since 1990), AM Best ICR a+ with a positive outlook (Nov-2025). Independent confirmation of balance-sheet repair and a genuine cost-of-capital reducer.
- Investment portfolio is predominantly high-grade fixed income with manageable duration; book value/share $74.24, tangible $66.76.
Free cash flow / capital generation (FACT). For an insurer, “FCF” is best read as subsidiary dividend capacity to the holding company plus underwriting cash generation. AIG generates ample holdco liquidity (it funded ~$19–20B of returns over three years) and operating cash flow per share of ~$5.86 (2025). Net income and cash from operations are not materially divergent once the deconsolidation noise is removed.
Verdict: high-quality balance sheet, clean-but-good (not elite) earning power, with one watch-item. AIG’s financials are now conservative and transparent once the Corebridge/AOCI distortions are normalized. Economics have improved with scale and discipline, but core operating ROE of ~11–12% is good, not exceptional, and the calendar combined ratio is modestly flattered by cycle help. The casualty reserve question is the one place where the accounting could surprise negatively. Net: the franchise’s economics support the current ~1.0x book valuation; they do not yet demand a re-rating toward peers.
7. Capital Allocation
The headline record is excellent (FACT). AIG’s capital allocation over 2022–2026 is the strongest among comparable insurers, and it is the dominant driver of shareholder value created in the period:
- Share count: 862M (2020) → 538M (2025), ~37% retired — roughly $22B of cumulative buyback (treasury stock rose from $49.3B to $71.2B). FY2025 alone: ~73M shares for ~$5.8B.
- ~$19–20B of total capital returned over three years ($4.0B / $8.1B / $6.8B in 2023/24/25, plus ~$0.76B Q1-26), funded by the ~$20B Corebridge monetization.
- Crucially, much was repurchased at or below book value in 2022–2024 — buying a dollar of book for ~80–95 cents is genuinely accretive to per-share book value and ROE, a textbook value-creating use of the deconsolidation proceeds.
- Dividend: raised to $0.50/quarter (Q2-2026, +11%) — the fourth consecutive double-digit annual raise — at a conservative ~31.5% payout (~2.7% yield at $74).
- Debt reduction: $30.2B → $9.19B, slashing interest expense and de-risking the holdco.
- Disposals at good prices, no dilutive M&A: Validus Re to RenaissanceRe (~$3.3B, 2023), Crop Risk Services, Glatfelter, and the staged Corebridge exit. AIG has been a net seller of non-core, not an empire-builder.
Compensation — a real governor (FACT). Unlike many names in our coverage that lack any return discipline in pay, AIG’s scheme is best-practice for a P&C insurer:
- Annual STIP: Core Operating ROE (25%) + Combined Ratio (25%) + Combined Ratio adjusted (25%) + Adjusted Pre-Tax Income (25%).
- PSUs: multi-year Combined Ratio (absolute and relative) + relative TSR, with no upside if absolute TSR is negative. The metric selection directly aligns pay with underwriting quality and returns — the right things. (Source: AIG DEF 14A.) Mild caveat: the latest PSU paid out at 161% of target, in a recovery year lifted by cyclical and one-time tailwinds, inviting the critique that management is being paid in part for the cycle and the buyback rather than purely for durable underwriting.
Insider behavior — neutral-to-mildly-negative (FACT). A scan of the trailing 24+ months of Form 4 activity (~160 of 572 filings reviewed) found zero open-market purchases (code P) by CEO Zaffino, the CFO, or any director — even when the stock traded below book in 2023–2024. Activity was entirely routine: grants (A), tax-withholding (F), option exercises (M), and planned sells (S). No conviction buy signal, but also no top-tick dumping.
Verdict: intelligent, disciplined, and shareholder-aligned — the strongest pillar of the thesis. Management monetized a non-core asset at scale, returned the proceeds accretively at/below book, de-levered, and pays itself on the right metrics. The one honest caveat is that the easiest value-creation lever — buying back stock below book — is largely exhausted now that the stock is at book; from here, capital allocation must shift toward deploying capital into underwriting (Everest, Convex, casualty), where the returns are less certain. The absence of any insider open-market buying is a missed opportunity to signal conviction.
8. Changes and Headwinds — Last Two Years
Strategic and structural changes (FACT) — net strengthening:
- Corebridge fully exited (~May 2026). The stake fell 10.1% (YE25) → 5.6% (Q1-26) → zero after Nippon Life waived AIG’s retention requirement (Feb 2026). The life/conglomerate overhang — a multi-year valuation suppressant — is gone. AIG is now a clean pure-play commercial P&C insurer.
- CEO transition (effective June 1, 2026). Eric Andersen (61, former President of Aon plc, ~30 years in insurance/broking) became President & CEO and joined the board; Peter Zaffino — the turnaround architect — became Executive Chair. Andersen joined as “President and CEO Elect” in February 2026 and reaffirmed all Investor Day targets on the Q1-26 call; CFO Keith Walsh and underwriting leadership provide continuity. (Sources: AIG 8-K filed 2026-04-27; Insurance Business, 2026-06-01.) Orderly, telegraphed, and continuity-oriented — but the execution premium AIG earned under Zaffino is now unproven under a new CEO. This is the single most important forward governance variable.
- “AIG Next” cost program exceeded its $500M run-rate savings target in 2025, pushing the GI expense ratio to 31.1% (target <30% by 2027) and supporting the >10% operating ROE.
- Validus Re divested to RenaissanceRe (closed Nov 1, 2023) — removed the most catastrophe-volatile earnings stream and de-risked the book.
- Ratings vindication (2025): the S&P/Moody’s/AM Best upgrades (above) — the external stamp on the balance-sheet repair.
- Escalating capital return: the fourth straight double-digit dividend raise and a ≥$1B 2026 buyback baseline plus the Corebridge proceeds.
Headwinds (FACT/INTERPRETATION):
- Property-rate softening at the top of the cycle — the cyclical headwind to commercial margins, with property pricing down 10–13% and large-account E&S down more.
- Latent casualty/social-inflation reserve risk — masked today by favorable short-tail development; the historical Achilles’ heel of the franchise.
- NII tailwind spent — investment income has plateaued, removing a multi-year earnings driver.
- Unproven post-Zaffino leadership — execution risk through a softening cycle under a CEO new to the company.
- The easy re-rating is done — the stock has already moved from ~0.6x to ~1.0x book; further multiple expansion now requires proof, not just balance-sheet repair.
Verdict: the structural changes decisively strengthen and de-risk the thesis; the headwinds are real but cyclical/execution, not existential. The debate has shifted from “can they fix it?” (answered: yes) to “can a now-good franchise sustain double-digit ROE and double-digit EPS growth through a softening cycle, under a new CEO, while the casualty book seasons cleanly?” The transformation is largely done and validated — which is exactly why the easy money may be behind the stock.
9. Risk Analysis (Risk Matrix)
| # | Risk | Likelihood | Impact | Evidence / basis |
|---|---|---|---|---|
| 1 | Casualty / social-inflation reserve deficiency | Medium | High | CFO adding margin to casualty picks; favorable PYD comes from short-tail, not casualty; franchise’s historical scar |
| 2 | Property-rate softening compresses margins | High | Medium | Property rates −10/−13%, E&S down ~30%; underlying AYCR flat ~88 — cycle help is fading |
| 3 | ROE stalls below ~12% = permanent sub-peer | Medium-High | Medium | Core op ROE 11.1% FY25; decade of 0.5–0.7x book; structural cost & personal-lines drags |
| 4 | Catastrophe shock (normal/heavy cat year) | Medium | Medium-High | 2025 cat load light ($258M); a normal/heavy year would lift the calendar combined ratio several points |
| 5 | New-CEO execution risk (Andersen, eff. 6/1/26) | Medium | Medium | Turnaround architect (Zaffino) stepped to Exec Chair; premium was earned under prior leadership |
| 6 | NII / interest-rate reversal | Medium | Medium | NII plateaued ~$4.07B; sharp rate cuts would pressure reinvestment yields and earnings |
| 7 | Soft-market underwriting indiscipline | Low-Medium | Medium | Comp governor + stated discipline mitigate; but soft markets historically erode standards industry-wide |
| 8 | Re-rating fails / multiple de-rates to <book | Medium | Medium | Already at rich end of own history (71st pctile); a disappointment could push back toward 0.85x book |
| 9 | Personal-lines drag persists / worsens | Medium | Low-Medium | Global Personal CR 99.0; being shrunk to quality but caps blended ROE |
| 10 | Macro/equity-market drawdown (low beta partial hedge) | Medium | Low-Medium | Beta 0.55, AA- balance sheet, capital return — relatively defensive, but not immune |
| 11 | Catastrophic/total loss | Very Low | High | AA- rated, $9.2B debt, diversified global book, heavy reinsurance — solvency risk is remote post-transformation |
Net risk read (INTERPRETATION): the dominant fundamental risk is casualty reserve adequacy colliding with a softening property cycle — the combination that could expose the underlying-vs-calendar combined-ratio gap. The dominant valuation risk is that the re-rating is already substantially banked, so a stumble de-rates rather than merely pauses the stock. Catastrophic loss risk is genuinely low after the de-levering and de-risking. The low beta and AA- balance sheet make AIG relatively defensive in a broad drawdown.
10. Valuation Discussion (Embedded Expectations)
No price target. No recommendation. This section analyzes what the price implies.
The right lens (INTERPRETATION). A P&C insurer’s justified price-to-book is governed by P/B ≈ (ROE − g) / (COE − g). Calibrating AIG: cost of equity (COE) ~9.5% (CAPM on beta 0.55 gives ~7%, but tail/reserve/catastrophe risk lifts the appropriate hurdle to ~9–10%); sustainable growth g ~4–5% (retained-equity growth plus modest buyback-at/below-book accretion).
What the price embeds (FACT/INTERPRETATION). At P/B = 1.0x, the identity collapses to ROE ≈ COE ≈ 9.5–10%. The market is underwriting AIG to earn approximately its cost of capital and no more — a value-neutral verdict, internally consistent with the ~10.4x multiple on AATI. Realized adjusted ROE is 9.4% and core operating ROE 11.1%, so the price is roughly fair-to-slightly-cheap against current earning power, with essentially no re-rating optionality priced in.
The re-rating sensitivity (the whole debate in one table):
| Sustainable ROE | Justified P/B (COE 9.5%, g 4.5%) | Implied price (BVPS $74.24) |
|---|---|---|
| 9.5% | 1.00x | ~$74 |
| 11.0% | 1.30x | ~$97 |
| 12.0% | 1.50x | ~$111 |
| 13.0% | 1.70x (≈ Chubb) | ~$126 |
| 14.0% | 1.90x | ~$141 |
Every ~150bps of durable ROE is worth roughly ~0.3x book ≈ ~$22/share. Chubb’s 1.7x book is the market saying “Chubb sustainably earns ~13–14%”; AIG’s 1.0x says “~9.5–10%.” The entire valuation gap is an ROE-durability judgment — not a balance-sheet, growth, or governance discount per se.
The own-history trap (FACT). Against the stock’s own ~10-year range, AIG is not cheap: AZI valuation percentiles are P/E 63.5th, P/B 70th, P/S 79th, composite 71st. AIG traded 0.5–0.7x book for its entire post-GFC decade, so ~1.0x is near the rich end of its own history even while it is the cheapest P/B of the quality peer set. Cheap vs. peers, full vs. itself — and which frame is right is the bull/bear debate.
Comp set (FACT). See the table (CB, TRV, WRB, ACGL). Insurance brokers (MMC, AON, AJG, BRO) are not valid multiple comps — they are capital-light fee businesses at ~20–30x earnings with no underwriting, reserve, or catastrophe risk on their own balance sheets. Comparing AIG’s ~10x earnings to a broker’s ~25x is a category error; AIG must be valued on book value and ROE.
Scenario analysis (INTERPRETATION — explicit assumptions):
- Bear (~$55–62): core operating ROE stalls at ~9–10%, soft property plus a casualty reserve scare pressures margins, the multiple de-rates to ~0.8–0.85x book. EPS/AATIps ~$6.5–7. An orderly de-rate, not a blow-up.
- Base (~$74–88): core operating ROE holds ~11–12%, combined ratio ~89–91, return ≈ book-value growth (~7–9%) plus buyback accretion and dividend, with little-to-no multiple expansion (1.0–1.15x book). AATIps grinds toward ~$8. This matches the sell-side average (~$86–88).
- Bull (~$100–125): core operating ROE proves durable at 12.5–13.5% through the soft cycle, the COE re-rates lower on the AA- balance sheet, and the multiple expands toward 1.3–1.5x book (half-converging to Chubb). AATIps ~$9+.
What the market is pricing correctly vs. incorrectly (INTERPRETATION). Correctly: the low ROE — 1.0x book honestly reflects a ~10% sub-peer return that the market quite reasonably insists be shown and held before paying more. Possibly incorrectly: the durability/optionality — if the fix is structural (expense discipline, exited bad books, AA- balance sheet, NII floor, disciplined comp), the option on convergence toward Chubb is close to free at 1.0x book. The bear’s counter is that the cycle is softening into the proof, so the option may expire worthless.
11. Variant Perception
Consensus (FACT). Constructive but not aggressive — roughly a “Moderate Buy” (approximately 8 buys / 14 holds / 0 sells), average price target ~$86–88 (range ~$80–101). Notably, the quality houses are Equal-Weight (Morgan Stanley EW $82, Apr-2026; Wells Fargo EW $87, Feb-2026) — the consensus translates to “fairly priced, modest upside, prove the ROE.” (Sources: TipRanks/MarketBeat AIG forecasts; GuruFocus, accessed 2026-06-21 — reported as consensus context, not the author’s view or target.)
Strongest bull case: (1) the ROE step-up is structural, not cyclical — core operating ROE 11.1% → 12.2% (Q1-26), GI underwriting income tripled in Q1; (2) re-rating optionality is near-free at 1.0x book — half the gap to Chubb is ~$97–104; (3) buyback at/below book has been genuinely accretive (shares −37%, ~$19–20B returned); (4) the ratings inflection lowers the cost of capital and supports a higher multiple; (5) a low-volatility, out-of-favor entry point in a defensive, capital-returning name.
Strongest bear case: (1) ROE is structurally stuck ~10–11% = permanently sub-peer (a decade of 0.5–0.7x book is the base rate); (2) the property cycle is softening into the proof — the combined-ratio improvement may be cyclical-peak; (3) latent casualty/social-inflation reserve risk — the franchise’s historical scar; (4) the NII tailwind is spent; (5) the re-rate has already happened (0.6x → 1.0x), so the easy money is gone; (6) new, unproven CEO.
The 3–5 assumptions that matter most: (i) sustainable core operating ROE (10% vs 12–13% is the whole valuation); (ii) combined-ratio durability through the soft market; (iii) casualty reserve adequacy; (iv) whether the COE re-rates lower (AA- balance sheet); (v) capital-return accretion now that the stock is at book.
Falsification tests. The bull thesis dies if: core operating ROE prints below 10% for two-plus quarters, the underlying combined ratio drifts above ~92, a casualty charge costs >1–2 points of ROE, or the stock fails to hold 1.0x book on good news. The bear thesis dies if: core operating ROE sustains 12%+ for 3–4 quarters while property rates fall, the underlying combined ratio holds 88–90, and the stock sustains a >1.15–1.2x book multiple.
Factor-positioning read (FACT). Beta 0.55, alpha +0.012, Industry:Insurance loading +0.76, LowVolatility +0.68; relative strength rs_12m −10%, rs_6m −11.3%, rs_ytd −12.4% — an out-of-favor, lagging, low-volatility value insurer, not a momentum name and not a violent falling knife (12-month max drawdown only ~17%, m3 +0.7%). The 3- and 5-year annualized returns (+12.5%/yr and +10.2%/yr) confirm the turnaround did pay; the recent fade is a give-back from the December-2025 peak. (Lifetime/rs_peak figures reflect the 2008 GFC near-wipeout and reverse split — ignore them.) This is the classic value/mean-reversion setup where consensus may be offsides on durability if the ROE proves out — and correctly cautious if it does not.
12. Fact vs. Interpretation Table
| # | Statement | Type | Basis |
|---|---|---|---|
| 1 | AIG is now a pure-play commercial-led P&C insurer; Corebridge fully exited ~May 2026 | Fact | FY2025 10-K; BusinessWire 2026-05-05 |
| 2 | FY25 GI NPW $23,675M; combined ratio 90.1; commercial ~73% of NPW | Fact | FY2025 10-K segment data |
| 3 | FY25 AATI $4,044M ($7.09/sh); core operating ROE 11.1%; Q1-26 12.2% | Fact | AIG adjusted disclosures; Q1-26 release |
| 4 | GAAP ROE 7.6% understates true earning power (Corebridge/AOCI distortion) | Interpretation | Reconciliation of GAAP vs adjusted |
| 5 | Underlying accident-year ex-cat combined ratio flat ~88 over 3 years | Fact | FY2025 10-K; transcripts |
| 6 | The calendar-CR improvement is partly cyclical (light cats + short-tail PYD), not all structural | Interpretation | Cat load $258M; PYD +$472M from property/financial lines |
| 7 | Shares −37% since 2020; ~$19–20B returned in 3 years, much at/below book | Fact | Per-share data; buyback disclosures |
| 8 | Capital allocation is the strongest pillar of the thesis | Interpretation | Buyback accretion + de-levering + dividend + comp governor |
| 9 | At 1.0x book the market prices sustainable ROE ≈ COE (~9.5–10%) — no re-rate optionality | Interpretation | Justified-P/B framework |
| 10 | AIG is cheap vs peers (CB 1.7x, TRV 2.0x) but rich vs its own history (71st pctile) | Fact | AZI valuation percentiles; peer reports |
| 11 | AIG lacks Chubb’s wide moat; it is a strong #3–#4 franchise | Interpretation | ROE gap despite near-peer commercial CR |
| 12 | Casualty/social-inflation reserve adequacy is the key unverifiable risk | Interpretation | CFO adding casualty margin; favorable PYD from short-tail |
| 13 | Eric Andersen became CEO eff. 6/1/26; Zaffino → Executive Chair | Fact | 8-K filed 2026-04-27; Insurance Business 2026-06-01 |
| 14 | Insiders bought zero shares on the open market through the turnaround | Fact | Form 4 corpus review |
| 15 | Ratings upgraded in 2025 (S&P AA-, Moody’s A1, AM Best a+/positive) | Fact | Agency releases, 2025 |
13. Open Questions
- Is the casualty book adequately reserved? Favorable development is coming from short-tail lines while the CFO adds margin to casualty — is that prudence sufficient against accelerating social inflation? Unverifiable from outside; the most important unknown.
- How durable is the ~88 underlying combined ratio as property rates fall 10–13%? Management concedes property attritional loss ratios are at “exceptional” (unsustainable) levels.
- Can Andersen sustain the execution premium? The turnaround architect has moved to Executive Chair; the operating culture is now tested under new leadership.
- What is the next leg of value creation now that buyback-below-book is exhausted? Management says deals (Everest, Convex) are “more accretive than buybacks” — will the deployed-capital returns validate that?
- Does the COE genuinely re-rate lower on the AA- balance sheet, or does the market keep AIG at its historical risk premium?
- What does a normal/heavy catastrophe year do to the calendar combined ratio after the unusually light 2025?
14. What Must Be True
For the bull case (re-rating toward ~$100–125):
- Core operating ROE sustains 12.5–13.5% for several quarters while property rates fall — proving the margin is structural, not cyclical.
- The underlying accident-year combined ratio holds ~88–90 through the soft market.
- The casualty book seasons cleanly — no material adverse reserve development.
- The market re-rates the COE lower on the AA- balance sheet, allowing the multiple to expand past ~1.15–1.2x book.
- Falsification test: if core operating ROE prints below 10% for two consecutive quarters, or a casualty reserve charge costs >1–2 points of ROE, the bull thesis is broken.
For the bear case (de-rating toward ~$55–62):
- Core operating ROE stalls at ~9–11%, confirming AIG as a permanent sub-peer earner.
- Softening property plus a casualty reserve scare pushes the underlying combined ratio toward/above ~92.
- The multiple de-rates back toward ~0.85x book as the “fixed franchise” narrative loses its re-rating premium.
- Falsification test: if core operating ROE sustains 12%+ for 3–4 quarters with property soft, and the stock holds >1.15x book, the bear thesis is broken.
The symmetry that matters: both falsification tests key off the same two observables — realized core operating ROE durability and the underlying combined ratio through the soft cycle. An investor need not predict the cycle; they need only watch whether AIG’s clean ROE holds above ~12% as property rates fall. That single metric resolves the debate.
15. Source Appendix
See the separate Source Appendix (Appendix B in the combined report) for the full list of primary filings (AIG FY2021–FY2025 10-Ks, FY2025/Q1-2026 results, DEF 14A, material 8-Ks including the 2026-04-27 CEO-transition filing), third-party fundamentals and price/valuation data (reconciled to filings), factor data, peer public filings (Chubb, Travelers), and dated public web sources for ratings actions, consensus, and the Corebridge/Andersen developments.
This is an independent research note for general information only and is not investment advice. The analysis is written position-free; the only directional view appears in the clearly-labeled opening opinion block, which is the author’s own subjective view.
APPENDIX A — Standard Diligence Questionnaire
American International Group, Inc. (NYSE: AIG) — supplemental to the research memo. Report date: 2026-06-21. Labels: FACT / INTERPRETATION / ASSUMPTION.
General
What thoughtful questions have other investors asked about this company? The dominant questions are: (1) Is AIG’s combined-ratio improvement structural or merely cyclical-peak help from a soft reinsurance market and a light catastrophe year? (2) Is the casualty/long-tail book adequately reserved against social inflation — the issue that nearly destroyed the franchise historically? (3) Now that the Corebridge separation and the buyback-below-book are essentially complete, what is the next leg of value creation, and can a new CEO (Eric Andersen, eff. 6/1/26) sustain it? (4) Does AIG deserve to break above 1.0x book toward Chubb’s 1.7x, or is ~10–11% ROE its ceiling? These are all variants of one question: is the fix durable enough to re-rate the stock further? (INTERPRETATION)
Cyclicality & Earnings Nature
Are earnings at a cyclical high or low? Closer to a cyclical high than a low on the property side. The 2021–2024 hard market and the NII surge lifted all P&C earnings; both are now fading (property rates −10/−13%, NII plateaued ~$4.07B). Casualty is earlier in its repricing cycle. AIG’s internal improvement (cost-out, exited bad books) is genuine and structural, but it is layered on top of cyclically elevated industry margins. (INTERPRETATION)
Driven by external environment or internal actions? Both — internal (AIG Next cost program, portfolio pruning, de-levering, buyback) and external (hard-market rates, higher investment yields, benign cats). The internal actions are the durable part; the external lift is mean-reverting. (INTERPRETATION)
How stable are revenues? Net premiums earned are reasonably stable and recurring (annual commercial renewals, sticky broker relationships), but reported “revenue” was massively distorted by the Corebridge deconsolidation ($52B→$26.8B). The underlying GI premium base is roughly flat (pruned by design). (FACT)
Outlook for products/services? Stable-to-modest. Commercial/specialty insurance is a mature, recurring product; demand grows roughly with global GDP and insured-value inflation. Forward growth is more about mix-shift (into casualty/specialty, out of soft property) and bolt-on deals (Everest, Convex) than organic expansion. (INTERPRETATION)
How big is this market, growing or shrinking, domestic or international? Global commercial P&C is a multi-hundred-billion-dollar premium market growing low-to-mid single digits; AIG is genuinely global (~190 jurisdictions, ~40% of Global Property international). The market is mature and competitive, not high-growth. (FACT/INTERPRETATION)
Business Quality & Competitive Moat
Is the industry getting more or less competitive? More — on property, where record reinsurance/ILS capacity is softening rates; somewhat less on casualty, where social inflation is hardening rates. Net: competitive intensity rising as the hard market fades. (INTERPRETATION)
How profitable is the business (ROIC, ROE)? Core operating ROE 11.1% (FY25), 12.2% (Q1-26); adjusted ROE 9.4%; GAAP ROE 7.6% (distorted). Good, not elite — below Chubb (~14–15%) and Travelers (~18–20%). ROIC is not the most meaningful metric for a levered insurer; ROE and combined ratio govern. (FACT)
How profitable is the industry — competitors, barriers to entry? Moderately profitable (sector ROEs fading toward ~10–12%). Barriers in specialty/E&S/multinational are real (licensing, scale, expertise, ratings) but shared among ~4–5 global carriers; commodity lines have low barriers. An oligopoly in the high-end niches, competitive elsewhere. (INTERPRETATION)
Can the business be easily understood? Moderately. The current pure-play P&C model is far simpler than the old conglomerate, but insurance accounting (reserves, AOCI, adjusted vs GAAP) requires expertise; the casualty reserve adequacy is genuinely hard to assess from outside. (INTERPRETATION)
Can it be undermined by foreign low-cost labor? No — insurance is a capital/expertise/regulatory business, not a labor-cost-arbitrage one. (FACT)
Do brands matter? Modestly. In complex commercial/multinational risks, claims-paying reputation and global servicing create captivity; in broker-intermediated commodity lines, price dominates. AIG’s brand was scarred in 2008 and has been substantially rehabilitated (ratings upgrades are the proof). (INTERPRETATION)
Nature of competition? Switching costs? Competition is on price, capacity, terms, and claims service, mediated by brokers. Switching costs are low-to-moderate — an annual renewal decision — higher for bespoke multinational programs, near-zero for commodity lines. (INTERPRETATION)
Financial Condition & Balance Sheet
Assets not fully recognized on the balance sheet? The franchise value of the rebuilt underwriting platform and the value of the float are not separately carried. AOCI was deeply negative (−$14.8B in 2023, reversing toward −$1.4B) — as bonds pull to par, adjusted book value benefits, a quiet under-recognized tailwind. (FACT/INTERPRETATION)
Off-balance-sheet liabilities? The key risk is under-reserving, not off-balance-sheet structures — loss reserves are on the balance sheet but their adequacy (esp. long-tail casualty) is an estimate. Heavy reinsurance use creates counterparty exposure. (INTERPRETATION)
How conservative is the accounting? Reasonably conservative now — the CFO is adding margin to casualty loss picks and harvesting favorable development from short-tail lines. The adjusted (AATI / core operating ROE) framework reconciles transparently to GAAP. The historical concern (prior-cycle reserve deficiency) argues for continued vigilance. (INTERPRETATION)
How CapEx-hungry? Not capital-expenditure-hungry in the industrial sense; the “capital” is underwriting/regulatory capital. The business generates ample holdco liquidity (funded ~$19–20B of returns in 3 years). (FACT)
Capital Allocation & Management
How much FCF, and how is it used? Strong holdco capital generation; used for ~$19–20B of buybacks and dividends over three years (much at/below book = accretive), de-levering ($30.2B→$9.2B debt), and selective bolt-ons. Philosophy: return excess capital, maintain a fortress balance sheet, deploy only at attractive returns. The strongest capital-allocation record among comparable insurers. (FACT/INTERPRETATION)
Significant acquisitions recently? AIG has been a net seller (Validus Re →RenRe ~$3.3B, Crop Risk Services, Glatfelter, Corebridge exit). Recent additive moves are capital-efficient: Everest renewal-rights (~$1.8B premium), ~35% Convex stake + quota share, fronting SPVs. No large dilutive M&A. (FACT)
Buying back shares? Yes, aggressively — ~37% of shares retired since 2020 (862M→538M), ~$22B cumulative. (FACT)
Issuing large amounts of new shares to insiders? No — routine equity comp (grants/RSUs/PSUs); net share count is falling sharply. (FACT)
Compensation policy of directors/management? Best-practice for a P&C insurer: STIP = Core Operating ROE + Combined Ratio (×2 variants) + Adjusted Pre-Tax Income; PSUs = multi-year combined ratio (abs + relative) + relative TSR, with no upside if absolute TSR is negative. A genuine return/underwriting governor. Caveat: latest PSU paid 161% of target in a recovery year. (FACT/INTERPRETATION)
Motivations of management? Aligned with underwriting quality and total return via the comp metrics. Mild negative: zero insider open-market purchases through the turnaround — no conviction signal. (FACT/INTERPRETATION)
Valuation & Market Data
Is the stock an ADR, MLP, or K-1 issuer? No — a US-domiciled C-corp common stock (NYSE: AIG), standard 1099 dividend reporting. (FACT)
Dividend policy? Quarterly cash dividend, $0.50/quarter (Q2-26, +11%) — fourth consecutive double-digit raise; ~31.5% payout; ~2.7% yield at $74. Conservative and growing. (FACT)
How profitable is the business? Core operating ROE ~11–12% — good, not elite. (FACT)
Is net income diverging from cash from operations? GAAP net income diverged sharply from operating reality due to Corebridge deconsolidation and AOCI; once normalized to AATI, earnings and operating cash flow are not materially divergent. Use adjusted metrics. (FACT/INTERPRETATION)
Risks & Downside
What factors would cause the stock to decline? A casualty/social-inflation reserve charge; the underlying combined ratio drifting above ~92 as property softens; a heavy catastrophe year; core operating ROE stalling below ~10–11%; a de-rating back toward 0.85x book if the “fixed franchise” re-rating premium fades; new-CEO execution stumbles; sharp interest-rate cuts pressuring NII. (INTERPRETATION)
Risk of a catastrophic loss? Low. AA- rated, $9.2B debt, globally diversified, heavily reinsured, near-1.0x book valuation with a conservative payout. Solvency risk is remote post-transformation. (INTERPRETATION)
Chance of a total loss? Very low absent a systemic insurance-industry catastrophe far beyond historical experience. The 2008-style existential risk was a function of the (now-divested) AIG Financial Products derivatives book and the life/securities-lending exposure — not the current pure-play P&C operation. (INTERPRETATION)
Recent News & Events
Has the business environment changed recently? Yes: (1) Corebridge fully exited (~May 2026) — pure-play P&C identity achieved; (2) CEO transition (Andersen in, Zaffino → Executive Chair, eff. 6/1/26); (3) 2025 ratings upgrades (S&P AA-, Moody’s A1, AM Best a+/positive); (4) property-rate softening began; (5) fourth straight double-digit dividend raise. (FACT)
Significant acquisitions? Additive: Everest renewal-rights, Convex stake. Net-seller posture otherwise. (FACT)
Change in accounting policies? No material policy change; the visible “change” is the deconsolidation of Corebridge, which cleaned up the reported financials. (FACT)
Recent changes — new markets, facilities, management? Management (new CEO); strategic re-deployment from soft property into casualty/specialty and bolt-on books; AIG Next operating-model simplification exceeding its $500M savings target. (FACT)
APPENDIX B — Source Appendix
American International Group, Inc. (NYSE: AIG) — Research note, report date 2026-06-21. Primary public sources first.
Primary — SEC filings (public, via EDGAR)
- AIG FY2025 Form 10-K (filed 2026-02-12;
aig-20251231.htm) — segment NPW & combined ratios, GI adjusted pre-tax income, NII, reserve development, AIG Next, capital, debt, ratings. Primary, authoritative. - AIG FY2021–FY2024 Form 10-Ks (2022-02-17 through 2025-02-14) — multi-year combined ratio, share count, book value, Corebridge deconsolidation, Validus disclosures.
- AIG Form 10-Q, Q1 2026 — core operating ROE 12.2%, AATI/sh $2.11, GI underwriting income $774M, combined ratio 87.3, property/casualty rate commentary.
- AIG DEF 14A (proxy) — STIP/PSU incentive metrics (Core Operating ROE, Combined Ratio, APTI, relative TSR), PSU payout 161%.
- AIG Form 8-K, filed 2026-04-27 (
a991-pzandeapr...htm) — CEO transition: Eric Andersen President & CEO eff. 6/1/26; Zaffino → Executive Chair. - AIG material 8-Ks (2021–2026) — Corebridge IPO (Sep-2022) and sell-downs, Validus Re sale (closed Nov-1-2023), buyback authorizations, dividend raises, ratings actions, quarterly earnings releases.
- AIG Form 3/4/5 insider filings (EDGAR) — insider transaction review: zero open-market purchases (code P) over trailing 24+ months; routine grants/withholding/exercises/planned sells only.
Primary — Company disclosures
- AIG adjusted financial supplements / Investor Day materials — AATI ($4,044M FY25; $7.09/sh diluted), adjusted ROE 9.4%, core operating ROE 11.1% FY25, “10%+” ROE target, capital-return totals, AIG Next $500M savings.
- AIG Q4-2025 and Q1-2026 earnings-call transcripts (public earnings calls) — forward combined-ratio framing, property −10/−13% vs casualty +8/+15%, NII outlook, Corebridge exit, Andersen reaffirming targets, casualty reserve-margin commentary.
Quantitative data sources (reconciled to filings)
- ROIC.ai MCP — income statement, per-share data, profitability ratios (ROE/ROA/ROIC), enterprise value (third-party aggregated; reconciled to 10-K). 2025: revenue $26.8B, net income $3.1B, diluted EPS $5.43, book value/share $74.24, tangible $66.76, shares 538M.
- AZI valuation_index (own-history percentiles) — P/E 13.2x (63.5th), P/B 0.99x (70th), P/S 1.57x (79th), composite 71st; latest price $74.02 (2026-06-18).
- AZI 5-year price CSV (
download-data.php?t=AIG) — five-year event map, 200-EMA (~$76.4), beta (~0.55). - FactorsToday — beta 0.55, alpha +0.012, Industry:Insurance +0.76, LowVolatility +0.68; rs_12m −10.0%, rs_6m −11.3%, rs_ytd −12.4%; leaderboard y3 +12.5%/yr, y5 +10.2%/yr, m6 −24.3% (annualized), y1 max drawdown −17%.
Peer comparison (public data)
- Chubb (NYSE: CB) — quality commercial-P&C benchmark; ~1.7x book, ~14–15% ROE, low-80s combined ratio.
- Travelers (NYSE: TRV) — direct P&C peer; ~2.0x book, ~18–20% ROE.
- Allstate (NYSE: ALL); W.R. Berkley (WRB); Arch Capital (ACGL) — additional P&C reference points.
Secondary — web sources (accessed 2026-06-21)
- Insurance Business / Global Reinsurance / Agency Checklists — “AIG completes planned CEO transition,” Andersen/Zaffino, June 2026.
- BusinessWire (2026-05-05), AM Best, Reinsurance News — Corebridge final exit / Nippon Life waiver.
- AM Best (news.ambest.com, 2026-11-20) — AIG positive outlook / a+ ICR; S&P AA- and Moody’s A1 upgrade releases (2025).
- TipRanks / MarketBeat / GuruFocus — consensus rating (~Moderate Buy), average price target ~$86–88, Morgan Stanley EW $82 (Apr-2026), Wells Fargo EW $87 (Feb-2026). Reported as consensus context only — not the author’s view or target.
Analytical frameworks
- Greenwald (Competition Demystified): moat-type classification (shared scale/captivity in specialty niches; not wide-moat). Marathon (Capital Returns): capital-cycle read on the softening property market.
All third-party aggregated data (ROIC.ai, AZI, FactorsToday) treated as a cross-check, reconciled to primary filings where material. Where a filing and an aggregator disagreed, the filing governs.